Gedik cuts Arcelik target to TRY 135.90 for Arcelik stock

Gedik Yatirim cut its Arcelik target from TRY 163.00 to TRY 135.90 on October 13, 2026, according to Foreks. The revised target is 16.63 percent below the former level, while the published note also reduced the recommendation from EUG to EPG.

Target cut resets valuation debate

The target revision gives investors a concrete counterweight to Arcelik's operating scale. The new TRY 135.90 objective stood 68 percent above the TRY 80.75 closing price cited in the October 13 report, although that comparison uses the market level in the analyst note rather than the later euro reference price.

The latest available Borsa Istanbul quote was TRY 78.40 on October 13, 2026 at 6:08 p.m. TRT. The share therefore sat TRY 57.50 below the revised target, while the 52-week Borsa Istanbul range was TRY 78.25 to TRY 136.00 as of the same market-data snapshot.

Three dated developments shape the stock

On June 30, 2026, Arcelik's second-quarter revenue was TRY 141.32 billion and net income was TRY 3.44 billion in the standardized financial record. For the first half of 2026, FVT reported net sales of TRY 280.7 billion, net profit of TRY 1.5 billion and FAVOK of TRY 14.2 billion.

On October 8, 2026, Arcelik Pazarlama signed a solar-panel supply contract worth USD 19.52 million with Smart Gunes Enerjisi's subsidiary, as CNBCE reported. The contract adds a quantified renewable-energy connection to the appliance group's broader operating profile.

What does the reporting date add?

Investing.com lists October 16, 2026 as the next earnings date for Arcelik's ADR. That date gives the market a near-term checkpoint for whether first-half sales of TRY 280.7 billion and net profit of TRY 1.5 billion are carrying into the next reporting period.

Stock stays near yearly low

Arcelik stock was last at TRY 78.40 on Borsa Istanbul on October 13, 2026 at 6:08 p.m. TRT. Its dated range floor was TRY 78.25, leaving the quoted level TRY 0.15 above the 52-week low and keeping the analyst target revision central to the valuation discussion.

Market context: Market report BIST 100.